Primary Peritoneal Carcinoma
Description
Primary peritoneal carcinoma (PPC) is a rare malignant tumor of the peritoneal cavity of extra-ovarian origin, clinically and histologically similar to advanced-stage serous ovarian carcinoma (see this term).
Clinical Features
Phenotypes and symptoms related to Primary Peritoneal Carcinoma
- Neoplasm
- Constipation
- Abdominal pain
- Nausea and vomiting
- Abdominal distention
- Peritonitis
Incidence and onset information
— Currently we don't have prevalence information about this disease (Not enough data available about incidence and published cases.)— No data available about the known clinical features onset.
Alternative names
Primary Peritoneal Carcinoma Is also known as primary peritoneal serous carcinoma, extra-ovarian primary peritoneal carcinoma, eoppc, serous surface papillary carcinoma, ppc.
Researches and researchers
Currently, we don't have any information about doctors, researches or researchers related to this disease. Please contact us if you would like to appear here.Primary Peritoneal Carcinoma Recommended genes panels
Panel Name, Specifity and genes Tested/covered |
---|
BRCA1.
By Molecular Diagnostic Laboratory University of Alberta (Canada).
BRCA1
Specificity
100 %
Genes
100 % |
MitoMet®Plus aCGH Analysis.
By Baylor Miraca Genetics Laboratories (United States).
RGS9, RHO, GRK1, RLBP1, RNASEL, BCS1L, RP1, RP2, RP9, RPE65, RPGR, RPL35A, MRPL3, RPS14, RS1, SAG, SARDH, SCO2, SCP2, SDHB , (...)
View the complete list with 612 more genes
Specificity
1 %
Genes
100 % |
BRCA1 & BRCA2 Seq and Del/Dup Analysis.
By Baylor Miraca Genetics Laboratories (United States).
BRCA1, BRCA2
Specificity
50 %
Genes
100 % |
Hereditary High Risk Breast Cancer Panel.
By Baylor Miraca Genetics Laboratories (United States).
BRCA1, BRCA2, STK11, TP53, CDH1, PALB2, PTEN
Specificity
15 %
Genes
100 % |
BRCA1 & BRCA2 Seq and Del/Dup Analysis.
By Baylor Miraca Genetics Laboratories (United States).
BRCA1, BRCA2
Specificity
50 %
Genes
100 % |
Hereditary High Risk Breast Cancer Panel.
By Baylor Miraca Genetics Laboratories (United States).
BRCA1, BRCA2, STK11, TP53, CDH1, PALB2, PTEN
Specificity
15 %
Genes
100 % |
Hereditary Prostate Cancer Panel.
By Baylor Miraca Genetics Laboratories (United States).
BRCA1, BRCA2, TP53, NBN
Specificity
25 %
Genes
100 % |
Hereditary Pancreatic Cancer Panel.
By Baylor Miraca Genetics Laboratories (United States).
BMPR1A, BRCA1, BRCA2, STK11, EPCAM, TP53, CDK4, CDKN2A, PALB2, APC, SMAD4, MLH1, MSH2, MSH6, ATM, PMS2, RAD50
Specificity
6 %
Genes
100 % |
You can get up to 346 more panels with our dedicated tool
Learn moreSources and references
You can check the following sources for additional information.
ORPHANET Genetic Syndrome FinderIf you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like ULNAR/FIBULAR RAY DEFECT AND BRACHYDACTYLY